Market Overview

PTC Therapeutics (NASDAQ: PTCT)

46.38 +0.97 (2.14%)

Earnings

QuarterPriorEstimateActualSurprise
Q2 2021
After-Hours
EPS:
REV:




Q1 2021
After-Hours
EPS:
REV:
-1.81
68.259M



Q4 2020
After-Hours
EPS:
REV:
-1.37
96.459M



Q3 2020
After-Hours
EPS:
REV:
-1.06
71.416M



Q2 2020
After-Hours
EPS:
REV:
-0.75
85.522M
-1.30
82.78M
-2.62
75.239M
-101.54%
-9.11%
Q1 2020
After-Hours
EPS:
REV:
-1.29
53.583M
-1.31
81.94M
-1.81
68.259M
-38.17%
-16.7%
Q4 2019
After-Hours
EPS:
REV:
-0.58
86.338M
-0.51
95.24M
-1.37
96.459M
-168.63%
1.28%
Q3 2019
After-Hours
EPS:
REV:
-1.06
53.591M
-0.76
73.02M
-1.06
71.416M
-39.47%
-2.2%
Q2 2019
After-Hours
EPS:
REV:
-0.21
68.743M
-0.58
78.64M
-0.75
85.522M
-29.31%
8.75%
Q1 2019
After-Hours
EPS:
REV:
-0.46
56.062M
-0.73
70.01M
-1.29
53.583M
-76.71%
-23.46%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!